# clm_260A5D665F9C

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: total_equity  
value: 1,356,405,000 United States dollar  
valid_from: 2013-12-31  
valid_to: 2014-03-31  
published: 2014-02-11  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_9AE7AF8EC0D1  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals total equity: 1,356,405,000 United States dollar", as of 2013-12-31 (until 2014-03-31). Claim clm_260A5D665F9C, https://asof.is/claim/clm_260A5D665F9C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532014000015/0000875320-14-000015-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-K FY2013, filed 2014-02-11  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532014000015/0000875320-14-000015-index.htm (primary, SEC EDGAR 10-K FY2013, published 2014-02-11)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | total_equity | 1,264,888,000 United States dollar | valid 2013-09-30 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_260A5D665F9C](/claim/clm_260A5D665F9C.md) | [clm_6D0B6A2430B2](/claim/clm_6D0B6A2430B2.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.